Harvard Bioscience (HBIO) Q3 2024 Earnings
HBIO·Reported November 7, 2024·Before market open
Harvard Bioscience reported Q3 2024 revenue of $22.0M, missed analyst consensus of $24.2M by $2.2M. Diluted EPS came in at $-0.02, missed the $-0.01 consensus by $0.01.
Revenue
$22.0Mmissed by $2.2M
Consensus: $24.2MDiluted EPS
$-0.02missed by $0.01
Consensus: $-0.01
Financial Snapshot
Trailing eight quarters through Q3 2024
Q3 2024 Earnings FAQ
Common questions about Harvard Bioscience's Q3 2024 earnings report.
Harvard Bioscience (HBIO) reported Q3 2024 earnings on November 7, 2024 before market open.
Harvard Bioscience reported revenue of $22.0M and diluted EPS of $-0.02 for Q3 2024.
Revenue missed the consensus estimate of $24.2M by $2.2M. EPS missed the consensus estimate of $-0.01 by $0.01.
You can read the 10-Q periodic report (0001171843-24-006181) directly on SEC EDGAR. The filing index links above go to sec.gov.